SCHEMBL7087545

SCHEMBL7087545

CC(=O)Nc1ccc(NC(=C2C(=O)Nc3ccc(N)cc32)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 5/20 0.46
AKT2 P31751 3/20 0.43
AKT1 P31749 1/20 0.43
LRRK2 Q5S007 1/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TP53 P04637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
JAK3 P52333 1/20 0.43
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
BRD4 O60885 1/20 0.41
BRD2 P25440 1/20 0.41
GSK3B P49841 1/20 0.41
NAPRT Q6XQN6 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
NOX4 Q9NPH5 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7087542 1.00 PDPK1 (0.46) PDPK1AKT2AKT1LRRK2MAPT
SCHEMBL7082903 0.92 PDPK1 (0.47) PDPK1AKT2AKT1MAPTJAK3
SCHEMBL7082906 0.92 PDPK1 (0.47) PDPK1AKT2AKT1MAPTJAK3
SCHEMBL29643001 0.91 PDPK1 (0.45) PDPK1AKT2AKT1JAK3BRD4
SCHEMBL7086761 0.91 PDPK1 (0.45) PDPK1AKT2AKT1JAK3BRD4
SCHEMBL7086762 0.91 PDPK1 (0.45) PDPK1AKT2AKT1JAK3BRD4
SCHEMBL7081846 0.90 PDPK1 (0.46) PDPK1AKT2AKT1ALDH1A1JAK3
SCHEMBL7081906 0.90 PDPK1 (0.44) PDPK1AKT2AKT1LRRK2MAPT
SCHEMBL7081841 0.90 PDPK1 (0.46) PDPK1AKT2AKT1ALDH1A1JAK3
SCHEMBL7081902 0.90 PDPK1 (0.44) PDPK1AKT2AKT1LRRK2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
EP-1071665-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES Boehringer Ingelheim Pharma KG (DE) 2001-01-31 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed
WO-1999052869-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-21 WO disclosed